Stasiak, P.; Sopel, J.; Płóciennik, A.; Musielak, O.; Lipowicz, J.M.; Rawłuszko-Wieczorek, A.A.; Sterzyńska, K.; Korbecki, J.; Januchowski, R.
Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs. Int. J. Mol. Sci. 2025, 26, 5800.
https://doi.org/10.3390/ijms26125800
AMA Style
Stasiak P, Sopel J, Płóciennik A, Musielak O, Lipowicz JM, Rawłuszko-Wieczorek AA, Sterzyńska K, Korbecki J, Januchowski R.
Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs. International Journal of Molecular Sciences. 2025; 26(12):5800.
https://doi.org/10.3390/ijms26125800
Chicago/Turabian Style
Stasiak, Piotr, Justyna Sopel, Artur Płóciennik, Oliwia Musielak, Julia Maria Lipowicz, Agnieszka Anna Rawłuszko-Wieczorek, Karolina Sterzyńska, Jan Korbecki, and Radosław Januchowski.
2025. "Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs" International Journal of Molecular Sciences 26, no. 12: 5800.
https://doi.org/10.3390/ijms26125800
APA Style
Stasiak, P., Sopel, J., Płóciennik, A., Musielak, O., Lipowicz, J. M., Rawłuszko-Wieczorek, A. A., Sterzyńska, K., Korbecki, J., & Januchowski, R.
(2025). Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs. International Journal of Molecular Sciences, 26(12), 5800.
https://doi.org/10.3390/ijms26125800
